Equity
Total Equity
Merck & Co. Total Equity decreased by 12.8% to $45.88B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $48.34B to $45.88B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 15.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2012
Last reportedQ1 2026May 4, 2026
How to read this metric
An increasing trend generally signals growth in retained earnings and shareholder value, while a decrease may indicate losses or significant share buybacks.
Detailed definition
Total stockholders' equity represents the residual interest in the assets of the entity after deducting all its liabilit...
Peer comparison
Varies significantly by industry based on capital intensity and historical profitability.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $33.29B | $35.79B | $38.18B | $40.88B | $43.24B | $44.46B | $45.99B | $46.83B | $38.69B | $41.25B | $37.58B | $40.36B | $43.58B | $44.50B | $46.31B | $48.34B | $48.99B | $51.85B | $52.61B | $45.88B |
| QoQ Change | — | +7.5% | +6.7% | +7.1% | +5.8% | +2.8% | +3.4% | +1.8% | -17.4% | +6.6% | -8.9% | +7.4% | +8.0% | +2.1% | +4.1% | +4.4% | +1.4% | +5.8% | +1.5% | -12.8% |
| YoY Change | — | — | — | — | +29.9% | +24.2% | +20.4% | +14.6% | -10.5% | -7.2% | -18.3% | -13.8% | +12.6% | +7.9% | +23.2% | +19.7% | +12.4% | +16.5% | +13.6% | -5.1% |
Range$33.29B – $52.61B
CAGR+7.0%
Avg YoY Growth+8.8%
Median YoY Growth+13.1%
Total Equity at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s total equity?
- Merck & Co. (MRK) reported total equity of $45.88B in Q1 2026.
- How has Merck & Co.'s total equity changed year-over-year?
- Merck & Co.'s total equity decreased by 5.1% year-over-year, from $48.34B to $45.88B.
- What is the long-term trend for Merck & Co.'s total equity?
- Over 5 years (2020 to 2025), Merck & Co.'s total equity has grown at a 15.8% compound annual growth rate (CAGR), from $25.32B to $52.61B.
- What does total equity mean?
- The total value of the company belonging to its shareholders after all debts are paid.